Tocilizumab in giant cell arteritis: Multicenter open-label study of 22 patients

TCZ therapy leads to rapid and maintained improvement in patients with refractory GCA and/or with unacceptable side effects related to corticosteroids. However, the risk of infection should be kept in mind when using this drug in patients with GCA.